January 16, 2017 12:00 pm
Published by jonas
January 16, 2017, Stockholm: Redwood Pharma AB (publ) has now according to plan completed optimization work surrounding the manufacturing process... View Article
December 21, 2016 12:00 pm
Published by jonas
The pace of Redwood Pharma development activities surrounding the company’s dry eye ophthalmic therapy RP101 has been high during the... View Article
November 8, 2016 12:00 pm
Published by jonas
On Saturday, November 19 Redwood Pharma AB will present at the conference ”Inspirationsträff för tjejer – Våga spara i aktier!”... View Article
October 7, 2016 12:00 pm
Published by jonas
Redwood Pharma’s RP101 ophthalmic drug development therapy uses the IntelliGel drug delivery platform. It has now been tested in an... View Article
September 20, 2016 12:00 pm
Published by jonas
Redwood Pharma AB (publ), a company that develops pharmaceuticals within ophthalmology, announces today that Ulf Björklund has accepted the company’s... View Article
September 16, 2016 12:00 pm
Published by jonas
Women make up two thirds of those suffering from Dry Eye Disease (DED). Presentations and scientific results shown at TFOS,... View Article
August 30, 2016 12:00 pm
Published by jonas
The granting of a Japanese patent for the IntelliGel® platform opens a significant global market within ophthalmic medicines to Redwood... View Article
August 11, 2016 12:00 pm
Published by jonas
On October 20th, Redwood Pharma AB (publ.) will present at the French-Swedish Life Science Day organized by Business Sweden, the... View Article
August 9, 2016 12:00 pm
Published by jonas
The 8th International Conference on the Tear Film & Ocular Surface: Basic Science and Clinical Relevance will occur from September... View Article
July 11, 2016 12:00 pm
Published by jonas
Redwood Pharma attending OIS-ASRS Conference in San Francisco Redwood Pharma AB (publ) announces that it will be attending the Ophthalmology... View Article